image
NRx Pharmaceuticals, Inc. NRXP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.19
2.59 %
$ 12.8 M
Market Cap
-0.44
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-27.6 M OPERATING INCOME
37.86%
Growth Rates
1Year 37.86%
3Years 18.73%
5Years -93.90%
7Years 0.00%
10Years 0.00%
-30.2 M NET INCOME
24.16%
Growth Rates
1Year 24.16%
3Years 16.49%
5Years -240.41%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall NRx Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 5 K
Gross Profit -5 K
Operating Expenses 27.6 M
Operating Income -27.6 M
Other Expenses 2.56 M
Net Income -30.2 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 5 K 4 K 2 K 0.9 0 1.0 0
Gross Profit 5 K 4 K 2 K (0.9) 0 (1.0) 0
OPERATING INCOME
Operating Expenses 27.6 44.4 94.4 11.9 6.43 K 1.0 0
Selling, General and Administrative Expenses 14.2 27.4 74.9 11.4 2.77 K 1.0 0
Research and Development Expenses 13.4 17.0 20.3 10.6 3.5 K 0 0
Operating Income (27.6) (44.4) (115.8) (51.4) 6.26 K (1.0) 0
PRE-TAX INCOME
Interest Income Expense 0.1 (4.6) 18 K 56 K 0 0 0
Total Other Income (2.6) 4.6 22.7 (39.9) 1.2 1.1 (0.1)
Pre-Tax Income (30.2) (39.8) (93.1) (51.8) 0.5 82.4 K (0.1)
NET INCOME
Tax Provision 9 K (4.6) (21.3) (39.4) 84.2 K 16.3 K 0
Net Income (30.1) (35.2) (71.7) (12.3) 0.4 66.1 K (0.1)
EPS 3.98 0.54 1.53 0.36 0.8 0.0741 0.12